IDIBAPS researchers have published in Nature Protocols the process for the directed differentiation of human induced pluripotent stem cells (iPSCs) into hepatic stellate cells (iPSC-HSCs).
Read more
The life science company Sartorius signed a strategic collaboration with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks, highly engineered media a...
Read more
The researchers, using real-time videos, have discovered that both the neurons and the cells of blood vessels emit dynamic protrusions to be able to ‘talk’ to each other.
Read more
Stem cells have been holding great promise for regenerative medicine for years. In the last decade, several studies have shown that this type of cell, which in Spanish is called “mother cell” beca...
Read more
Last week , our colleagues Marta Rayo and Marta Morales participated in the nTRACK 30 MM follow up meeting to discuss the project progress with all the partners.
Read more
Treatment with mesenchymal stem cells (MSCs), extracted from fat tissue, is a powerful tool for the cure of autoimmune diseases such as Crohn’s disease.
Read more
Replacing the cells of a damaged tissue with healthy ones using stem cells is now a reality.
Read more
A collaboration research between Achucarro and the UPV/EHU discovers that dental pulp stem cells are able to integrate and generate brain neovasculogenesis
Read more
In June 2017, researchers from the IIB-Sant Pau, the Institute of Biotechnology and Biomedicine at the UAB and the CIBER-BBN, created a spin-off, Nanoligent, with the goal of developing the first drug...
Read more
Researchers at IRB Barcelona unravel the role of the histone BigH1 in the development of male sex cells from stem cells. The study, which was performed in Drosophila melanogaster, paves the way to a ...
Read more
In EMBO Molecular Medicine, IRB Barcelona scientists report a technique based on a combination of CRISPR/Cas9 genome editing and patient-derived tumour organoids that allows the study of cell heteroge...
Read more
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG) (“TiGenix”) today announced new data from the Phase 3 ADMIRE-CD clinical trial, ...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
Con una estrategia de expansión comercial internacional, CIRCE Scient...
